<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04388150</url>
  </required_header>
  <id_info>
    <org_study_id>0201288</org_study_id>
    <nct_id>NCT04388150</nct_id>
  </id_info>
  <brief_title>Efficacy of Narrow Band Spectrum Endoscopy for the Diagnosis of Gastric Antral Vascular Ectasia in Patients With Liver Cirrhosis</brief_title>
  <official_title>Efficacy of Narrow Band Spectrum Endoscopy Versus Histopathology for the Diagnosis of Gastric Antral Vascular Ectasia in Patients With Liver Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the study aims to evaluate the role of similar technology of Narrow Band Imaging VIST video
      intelligent staining technology in the diagnosis of Gastric Antral Vascular ectasia in
      cirrhotic patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      VIST (Video intelligent staining technology) is used to the diagnosis of GAVE as the form of
      ectatic vessels in the antrum in instead of erosions in the antrum by White light endoscopy
      which can mislead the diagnosis to Portal hypertension gastropathy. Targeted biopsies are
      taken and examined histopathologically in order to see if matching with VIST view. In
      addition, CD61 is used to highlight the diagnosis for more confirmation. CD61 is an
      immunohistochemistry platelets marker.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 11, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of Narrow Band Spectrum endoscopy for the diagnosis of Gastric antral vascular ectasia in cirrhotic patients</measure>
    <time_frame>it is estimated to be 12 months</time_frame>
    <description>It is done by the new technology of VIST which is similar to Narrow Band Imaging in the diagnosis of Gastric antral vascular ectasia in cirrhotic patients that were misdiagnosed before as portal hypertension gastropathy</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gastric Antral Vascular Ectasia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Upper gastrointestinal endoscopy and biopsy</intervention_name>
    <description>Gastroscope with technology of VIST video intelligent staining technology for taking biopsies</description>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      biopsies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population includes all cirrhotic patients undergoing Upper gastrointestinal
        endoscopy and they have antral erosions by endoscopy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with mucosal vascular lesions at the gastric antrum suspicious of GAVE of a
             linear striped form or a diffuse punctate form upon conventional WLE

        Exclusion Criteria:

          -  Connective tissue disorders like systemic sclerosis.

          -  Chronic kidney disease.

          -  Recent use of proton pump inhibitors in the last 14 days.

          -  History of gastric surgery or gastric cancer.

          -  Pernicious anemia.

          -  Recent history of non-steroidal anti-inflammatory drugs intake
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randa Salah Eldin Abdelmoneim, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandria University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amr Abd Elmoety, PhD</last_name>
    <phone>00201111168555</phone>
    <email>amrmoety@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Perihan Salem, PhD</last_name>
    <phone>00201001815239</phone>
    <email>drperihansalem@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Internal Medicine, Hepatology Unit. Faculty of Medicine, Alexandria University</name>
      <address>
        <city>Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 11, 2020</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2020</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Randa Salah</investigator_full_name>
    <investigator_title>Assistant lecturer, Internal Medicine Department</investigator_title>
  </responsible_party>
  <keyword>Narrow Band</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Gastric Antral Vascular Ectasia</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

